Company Filing History:
Years Active: 2022
Title: **Jing Cheng: Innovating Pharmacological Solutions**
Introduction
Jing Cheng, an inventor based in Shandong, China, is making significant strides in the pharmaceutical field with a focus on innovative drug development. With one patent to his name, Jing is contributing to advancements in the treatment of FXR-mediated diseases.
Latest Patents
His patent, titled "FXR agonist," pertains to a compound that includes various pharmaceutical forms such as salts, esters, and stereoisomers. The invention outlines a preparation method for these compounds, alongside pharmaceutical compositions and formulations. Notably, it describes the application of the compound for the creation of medicaments aimed at treating and preventing FXR-mediated conditions, showcasing Jing's commitment to addressing critical health issues.
Career Highlights
Jing Cheng is currently associated with Xuanzhu Biopharmaceutical Co., Ltd., where he plays a pivotal role in research and development. His work not only emphasizes his expertise but also reflects his dedication to improving healthcare through innovative solutions.
Collaborations
Collaborating closely with talented professionals such as Wenkui Ken Fang and Bo Chen, Jing fosters an environment of creativity and innovation. These collaborative efforts strengthen the research initiatives within Xuanzhu Biopharmaceutical Co., Ltd. and enhance the potential for groundbreaking advancements in pharmaceuticals.
Conclusion
With his patent and ongoing work at Xuanzhu Biopharmaceutical Co., Ltd., Jing Cheng exemplifies the spirit of innovation in the pharmaceutical industry. His contributions are vital for the development of effective treatments for diseases, demonstrating the crucial intersection of invention and healthcare.